Barclays PLC Abbott Laboratories Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$100.07 - $118.13 $40.4 Million - $47.7 Million	-404,000 Reduced 98.63%	5,600 $638,000
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $41.3 Million - $46.1 Million	409,600 New	409,600 $42.6 Million
Q4 2023 Feb 15, 2024	BUY	$90.19 - $110.4 $1.88 Million - $2.3 Million	20,800 Added 208.0%	30,800 $3.39 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $8.02 Million - $9.63 Million	-84,000 Reduced 89.36%	10,000 $968,000
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $9.47 Million - $10.6 Million	94,000 New	94,000 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $18.6 Million - $22.8 Million	161,200 Added 110.03%	307,700 $43.3 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $5.49 Million - $6.67 Million	-59,900 Reduced 29.02%	146,500 $15.9 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $467,076 - $597,800	-6,100 Reduced 2.87%	206,400 $18.9 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $9.64 Million - $14.1 Million	-153,500 Reduced 41.94%	212,500 $16.8 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $5.74 Million - $6.39 Million	73,100 Added 24.96%	366,000 $31.8 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $6.47 Million - $7.01 Million	-79,000 Reduced 21.24%	292,900 $24.5 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $51,016 - $59,500	700 Added 0.19%	371,900 $31.3 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $26.7 Million - $32.3 Million	-403,200 Reduced 52.07%	371,200 $29.7 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $8.53 Million - $9.66 Million	130,100 Added 20.19%	774,400 $56 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $10.7 Million - $12.9 Million	175,300 Added 37.38%	644,300 $47.3 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $9.3 Million - $10.3 Million	161,600 Added 52.57%	469,000 $28.6 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $11.1 Million - $12.5 Million	-197,100 Reduced 39.07%	307,400 $18.4 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $2.48 Million - $2.66 Million	46,200 Added 10.08%	504,500 $28.8 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $22 Million - $24.6 Million	458,300	458,300 $24.5 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.2 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.76 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.51 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.09 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account